Immune System Regulation AB

Immune System Regulation AB is an innovation-driven research company based at the Karolinska Hospital in Stockholm, Sweden. The company's objective is to develop drugs for the treatment of viral infections and cancer through a focus on preclinical and clinical research within the field of immunotherapy. With a mission to be at the forefront of immunotherapy, ISR aims to develop curative drugs for cancer, HIV, Covid-19, HBV, and other infections. The company's dedication to advancements in immunotherapy positions it as a key player in addressing critical medical challenges. As an investor, keeping an eye on ISR and its pioneering work in the development of treatments for impactful diseases presents an opportunity to contribute to groundbreaking advancements in medical science.